Aarkstore.com announce The Latest report -Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012
http://www.aarkstore.com/reports/Intarcia-Therapeutics-Inc-Product-
Pipeline-Review-2012-217891.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Market Direct’s pharmaceuticals report, “Intarcia Therapeutics, Inc. - Product
Pipeline Review - 2012” provides data on the Intarcia Therapeutics, Inc.’s research
and development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Intarcia Therapeutics, Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Intarcia Therapeutics,
Inc. and industry-specific third party sources, put together by Global Markets
Direct’s team.
Scope
- Intarcia Therapeutics, Inc. - Brief Intarcia Therapeutics, Inc. overview including
business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Intarcia Therapeutics, Inc. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,

2. including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 4
List of Figures 4
Intarcia Therapeutics, Inc. Snapshot 5
Intarcia Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
Intarcia Therapeutics, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Intarcia Therapeutics, Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Intarcia Therapeutics, Inc. – Pipeline Products Glance 11
Intarcia Therapeutics, Inc. – Late Stage Pipeline 11
Phase III Products/Combination Treatment Modalities 11
Intarcia Therapeutics, Inc. Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
Intarcia Therapeutics, Inc. – Drug Profiles 13
ITCA 638 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ITCA 638 + Ribavirin 14
Product Description 14
Mechanism of Action 14
R&D Progress 15
ITCA 650 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ITCA 880 18
Product Description 18
Mechanism of Action 18

3. R&D Progress 18
ITCA 884 19
Product Description 19
Mechanism of Action 19
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review&PubId=&pagenum=1
Infinity Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Intarcia Therapeutics, Inc. – Product Pipeline Review – 2012
InterMed Discovery GmbH – Product Pipeline Review – 2012
Jenrin Discovery, Inc. – Product Pipeline Review – 2012
M et P Pharma AG – Product Pipeline Review – 2012
Fresenius Biotech GmbH – Product Pipeline Review – 2012
Evolva SA – Product Pipeline Review – 2012
Glycotope GmbH – Product Pipeline Review – 2012
Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012

4. Helsinn Healthcare S.A. – Product Pipeline Review – 2012
Hygeia Therapeutics, Inc. – Product Pipeline Review – 2012
IkerChem S.L. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on
sample@aarkstore.com
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com